Related Experiment Video
Updated: Feb 10, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Development of a Patient-Level Multi-objective Optimisation Model for Screening Strategies for Childhood Type 1
Gonçalo Leiria1, R Brett McQueen2, Conner Jackson2
1Department of Computer Science, University of Exeter, Exeter, UK.
Insights
This study developed a patient-level simulation model for type 1 diabetes (T1D) screening. Optimal strategies were identified, balancing cost-effectiveness and minimizing diabetic ketoacidosis (DKA) events.
Area of Science:
- Computational modeling and simulation
- Public health and epidemiology
- Endocrinology and metabolic diseases
Background:
- Type 1 diabetes (T1D) is a chronic autoimmune disease requiring lifelong management.
- Early detection of pre-symptomatic T1D can potentially improve outcomes and reduce complications.
- Current screening strategies for T1D are not universally established or optimized for cost-effectiveness.
Purpose of the Study:
- To develop a comprehensive patient-level simulation model for T1D, encompassing childhood and adulthood.
- To identify and evaluate the cost-effectiveness of optimal screening strategies for pre-symptomatic T1D.
- To balance screening costs, clinical benefits (life years gained), and patient burden (e.g., number of tests).
Main Methods:
- A Python-based patient-level simulation model was created to track 100,000 participants.
- A multi-objective optimization approach (NSGA-II algorithm) was employed to minimize cost-effectiveness ratio, diabetic ketoacidosis (DKA) events, and the number of screening tests.
- The model incorporated data from large-scale screening studies, risk functions, and clinical trials for transition probabilities.
Main Results:
- Four optimal T1D screening strategies were identified in the USA, meeting common cost-effectiveness thresholds.
- These strategies involve a maximum of 1, 2, 3, or 4 islet autoantibody (IA) tests.
- The model demonstrated the utility of multi-objective optimization in patient-level simulations for T1D screening.
Conclusions:
- The developed patient-level simulation model and optimization pipeline offer a valuable reference for T1D screening research.
- The identified strategies provide evidence-based options for implementing cost-effective T1D screening programs.
- Further application of this methodology can aid in refining public health strategies for T1D prevention and management.
Objective:
To develop a patient-level simulation model of type 1 diabetes (T1D) covering both childhood and adulthood. The goal is to identify and evaluate the cost-effectiveness of optimal screening for pre-symptomatic T1D.
Methods:
We developed a Python-based simulation model to track 100,000 participants screened in childhood, capturing a subset of those at risk and transitioning to T1D, to estimate the incremental cost-effectiveness per life year gained of screening versus no screening. Our multi-objective optimisation approach sought to minimise three objectives: incremental cost effectiveness ratio, diabetic ketoacidosis (DKA) events at onset and the maximum number of screening tests a child can have with the healthcare system. The NSGA-II algorithm is used to explore the set of possible screening strategies from combinations of genetic risk score (GRS) and islet autoantibody (IA) measurements at different ages and frequencies during the first 15 years of life. Data for transition probabilities include large scale screening studies such as The Environmental Determinants of Diabetes in the Young, TrialNet, published risk functions, clinical trials and epidemiologic studies.
Results:
We illustrate the use of multi-objective optimisation in patient-level simulations by estimating an optimal subset of T1D screening strategies in the USA. We identify four screening strategies with incremental cost-effectiveness ratios that meet commonly cited cost-effectiveness thresholds, which require, respectively, a maximum of 1, 2 3 and 4 islet autoantibody (IA) tests.
Conclusions:
This article and corresponding model code can be used as a reference for implementing a multi-objective optimisation pipeline in patient-level simulation models.
Related Concept Videos
Erikson's Theory on Socioemotional Development during Childhood
The first four of Erikson's eight...
Piaget's Theory of Cognitive Development from Childhood into Adulthood
Schemata: Building Blocks of Knowledge
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Titrimetric Methods: Types and Commonly Used Strategies
Piaget's Stage 1 of Cognitive Development
Exploration...

